BSN.DEBSN.DEXETRA
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR+189.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+189.2%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
24.2x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 7.16% |
| 2024 | 12.31% |
| 2023 | 17.40% |
| 2022 | 0.30% |
| 2021 | 4.64% |
| 2020 | -7.98% |
| 2019 | 4.15% |
| 2018 | -1.46% |
| 2017 | 2.70% |
| 2016 | 8.47% |